ErbB2/Her2 Antikörper
Kurzübersicht für ErbB2/Her2 Antikörper (ABIN2473977)
Target
Alle ErbB2/Her2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT." in: Molecular cancer therapeutics, Vol. 5, Issue 5, pp. 1197-208, (2006) (PubMed).
-
: "Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT." in: Molecular cancer therapeutics, Vol. 5, Issue 5, pp. 1197-208, (2006) (PubMed).
-
- ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))
-
Andere Bezeichnung
- HER2/neu
-
Hintergrund
- Synonyms: CD340
-
Gen-ID
- 2064
-
UniProt
- P04626
-
Pathways
- RTK Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Skeletal Muscle Fiber Development
Target
-